JP2025511289A5 - - Google Patents
Info
- Publication number
- JP2025511289A5 JP2025511289A5 JP2024558264A JP2024558264A JP2025511289A5 JP 2025511289 A5 JP2025511289 A5 JP 2025511289A5 JP 2024558264 A JP2024558264 A JP 2024558264A JP 2024558264 A JP2024558264 A JP 2024558264A JP 2025511289 A5 JP2025511289 A5 JP 2025511289A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210345707.0A CN116925233A (zh) | 2022-04-02 | 2022-04-02 | 抗tigit-抗pvrig双特异性抗体、其药物组合物及用途 |
| CN202210345707.0 | 2022-04-02 | ||
| PCT/CN2023/085428 WO2023186081A1 (zh) | 2022-04-02 | 2023-03-31 | 抗tigit-抗pvrig双特异性抗体、其药物组合物及用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511289A JP2025511289A (ja) | 2025-04-15 |
| JP2025511289A5 true JP2025511289A5 (https=) | 2026-04-06 |
Family
ID=88199468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558264A Pending JP2025511289A (ja) | 2022-04-02 | 2023-03-31 | 抗ｔｉｇｉｔ－抗ｐｖｒｉｇ二重特異的抗体、その医薬組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250223354A1 (https=) |
| EP (1) | EP4506365A4 (https=) |
| JP (1) | JP2025511289A (https=) |
| KR (1) | KR20240164815A (https=) |
| CN (2) | CN116925233A (https=) |
| AU (1) | AU2023247712A1 (https=) |
| CA (1) | CA3255478A1 (https=) |
| CL (1) | CL2024002975A1 (https=) |
| IL (1) | IL316008A (https=) |
| MX (1) | MX2024012144A (https=) |
| WO (1) | WO2023186081A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116135884A (zh) * | 2021-11-17 | 2023-05-19 | 普米斯生物技术(珠海)有限公司 | 抗tigit-抗pd-l1双特异性抗体、其药物组合物及用途 |
| CN114414808A (zh) * | 2021-12-07 | 2022-04-29 | 上海药明生物医药有限公司 | 一种检测tigit抗体和pvrig抗体的协同生物学活性的方法 |
| CN120230207A (zh) * | 2023-12-29 | 2025-07-01 | 百奥泰生物制药股份有限公司 | Pvrig结合蛋白、双特异性抗体及其应用 |
| CN119431583B (zh) * | 2024-12-19 | 2025-09-30 | 重庆国际免疫创新中心有限公司 | 靶向cd155的抗体或抗原结合片段及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| KR102236367B1 (ko) | 2013-07-26 | 2021-04-05 | 삼성전자주식회사 | DARPin을 포함하는 이중 특이 키메라 단백질 |
| CA2942546C (en) | 2014-03-17 | 2022-11-22 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| DK3653221T5 (da) | 2015-02-19 | 2024-08-26 | Compugen Ltd | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder |
| US10407484B2 (en) * | 2015-09-02 | 2019-09-10 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for modulating T-cell mediated immune response |
| KR20210016448A (ko) * | 2018-06-01 | 2021-02-15 | 컴퓨젠 엘티디. | 항-pvrig/항-tigit 이중특이적 항체 및 사용 방법 |
| MX2021000745A (es) * | 2018-07-20 | 2021-03-26 | Surface Oncology Inc | Composiciones anti-cd112r y metodos. |
| CN113164766B (zh) | 2018-10-23 | 2025-02-25 | 供石公司 | RGMc选择性抑制剂及其用途 |
| CA3170025A1 (en) * | 2020-03-13 | 2021-09-16 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Pvrig binding protein and its medical uses |
-
2022
- 2022-04-02 CN CN202210345707.0A patent/CN116925233A/zh active Pending
-
2023
- 2023-03-31 EP EP23778445.9A patent/EP4506365A4/en active Pending
- 2023-03-31 KR KR1020247036669A patent/KR20240164815A/ko active Pending
- 2023-03-31 WO PCT/CN2023/085428 patent/WO2023186081A1/zh not_active Ceased
- 2023-03-31 IL IL316008A patent/IL316008A/en unknown
- 2023-03-31 AU AU2023247712A patent/AU2023247712A1/en active Pending
- 2023-03-31 US US18/852,935 patent/US20250223354A1/en active Pending
- 2023-03-31 JP JP2024558264A patent/JP2025511289A/ja active Pending
- 2023-03-31 CA CA3255478A patent/CA3255478A1/en active Pending
- 2023-03-31 CN CN202380031275.9A patent/CN118946592A/zh active Pending
-
2024
- 2024-09-30 MX MX2024012144A patent/MX2024012144A/es unknown
- 2024-10-02 CL CL2024002975A patent/CL2024002975A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025511289A5 (https=) | ||
| JP2025111463A5 (https=) | ||
| JP2023129543A5 (https=) | ||
| CN102369214B (zh) | 三价、双特异性抗体 | |
| JP2020514277A5 (https=) | ||
| JP2023516004A5 (https=) | ||
| JP2025511288A5 (https=) | ||
| JP2024527288A5 (https=) | ||
| JP2022509156A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2024504390A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2023549537A5 (https=) | ||
| JP2024538669A5 (https=) | ||
| JP2023529842A5 (https=) | ||
| JP7675818B2 (ja) | 抗クローディン－１８．２抗体及びその抗体薬物複合体 | |
| JP2022553922A5 (https=) | ||
| JP2024542192A5 (https=) | ||
| JP2023536461A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2020513759A5 (https=) | ||
| JP2024532836A5 (https=) | ||
| JP2023516941A5 (https=) | ||
| WO2023186063A1 (zh) | 抗pvrig抗体、其药物组合物及用途 |